15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Adient PLC, 6 rate it Buy or better, 3 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $20.00 to $34.00, a moderate spread. The average target of $28.30 sits 31% above the current $21.62. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 6 over recent months. On the fundamentals, the Street sees revenue growth near 2% this year and 2% next, consensus EPS building from about $0.71 next quarter toward $3.28 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy660%
Hold330%
Sell110%
Strong Sell00%
Based on 10 analysts giving stock ratings to Adient PLC.
As of Jul, 6 of 10 firms rate ADNT a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ADNT EPS & revenue forecast
EPS · NEXT QUARTER
$0.71
Range $0.53 – $0.82 · 12 analysts · +37% YoY
Next period, 12 analysts expect Adient PLC to earn $0.71 a share (range $0.53 – $0.82), versus $0.52 a year earlier. Full-year consensus is $2.15, growing to $3.28 the year after.
REVENUE · NEXT QUARTER
$3.6B
Range $3.6B – $3.8B · 12 analysts · -1% YoY
Revenue is expected to reach $3.6B (range $3.6B – $3.8B), -1.0% year-over-year. Full-year consensus is $14.9B, rising to $15.1B next year.
Top analysts covering Adient PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADNT.
#1
Nathan Jones
Stifel · Rank #102
Buy
$28.00+29.5% to target
Overall win rate
49%
+ Follow
#2
Joseph Spak
UBS
Buy
$34.00+57.3% to target
Coverage
—
+ Follow
#3
Colin Langan
Wells Fargo
Buy
$32.00+48.0% to target
Coverage
—
+ Follow
#4
Dan Levy
Barclays
Hold
$29.00+34.1% to target
Coverage
—
+ Follow
#5
RB
Ryan Brinkman
JP Morgan
Hold
$26.00+20.3% to target
Coverage
—
+ Follow
ADNT stock forecast FAQ
What is ADNT's average 12-month price target?+
The 10 analysts with a live target average $28.30 for Adient PLC over the next 12 months, ranging from a $34.00 high to a $20.00 low.
Is ADNT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 6 are Buy or Strong Buy, 3 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ADNT?+
The Street-high target is $34.00 (UBS), and the Street-low is $20.00 (B of A Securities). The average of all 10 active targets is $28.30.
How many Wall Street analysts cover ADNT?+
10 analysts have an active rating on Adient PLC, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering ADNT?+
Among analysts who currently cover ADNT, Nathan Jones of Stifel has the strongest overall Quantellect track record (Rank #102). Their current call is Buy with a $28.00 target.
What is Adient PLC's projected EPS for next quarter?+
The consensus estimate is $0.71 per share (range $0.53 – $0.82) across 12 analysts. Full-year EPS is projected at $2.15, rising to $3.28 the following year.
How much revenue is Adient PLC expected to report next quarter?+
Consensus revenue is $3.6B (range $3.6B – $3.8B). Full-year revenue is projected at $14.9B, growing to $15.1B next year.
Have analysts been upgrading or downgrading ADNT lately?+
As of Jul, 6 of 10 firms rate ADNT a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADNT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
